• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 6
  3. Author

Online ISSN: 2515-8260

Volume9, Issue6

Comparative study between 20ml of 0.5% ropivacaine and 20ml of 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries

    Dr. Karthik M, Dr. Gowthaman R,Dr Santhosh Tamilarasan Dr. Subbulakshmi Sundaram

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 6, Pages 2535-2546

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: This study is aimed to compare the effects between 20ml of 0.5% Ropivacaine and 20ml
of 0.5% Levobupivacaine in ultrasound guided supraclavicular brachial plexus block for
Upper limb surgeries.
Methodology: It was a prospective double blinded randomized controlled study in sixty adult
patients undergoing upper limb surgeries admitted in Rajah Muthiah Medical college and
hospital from November 2020 to November 2022.
Result: Significant earlier onset of sensory blockade (p=0.001) and motor blockade (p=0.001),
prolonged duration of sensory and motor blockade (p=0.001) was observed in group of
patients receiving 0.5% levobupivacaine compared to 0.5% ropivacaine. Intraoperatively
throughout the study heart rate (HR), systolic blood pressure (SBP) and diastolic blood
pressure (DBP) were comparable in both the groups and found no statistically significant
difference (p>0.05). The heart rate, systolic and diastolic blood pressure for both the groups
were also compared postoperatively and observed no significant statistical difference (p>0.05).
No adverse effects were observed in both the groups.
Conclusion: 0.5% levobupivacaine used in ultrasound guided supraclavicular brachial plexus
block for upper limb surgeries provides rapid onset of sensory and motor blockade and
prolonged duration of analgesia compared to 0.5% ropivacaine
Keywords:
    Ultrasound guided supraclavic block ropivacaine Levobupivacaine upper
  • PDF (477 K)
  • XML
(2022). Comparative study between 20ml of 0.5% ropivacaine and 20ml of 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries. European Journal of Molecular & Clinical Medicine, 9(6), 2535-2546.
Dr. Karthik M, Dr. Gowthaman R,Dr Santhosh Tamilarasan Dr. Subbulakshmi Sundaram. "Comparative study between 20ml of 0.5% ropivacaine and 20ml of 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries". European Journal of Molecular & Clinical Medicine, 9, 6, 2022, 2535-2546.
(2022). 'Comparative study between 20ml of 0.5% ropivacaine and 20ml of 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries', European Journal of Molecular & Clinical Medicine, 9(6), pp. 2535-2546.
Comparative study between 20ml of 0.5% ropivacaine and 20ml of 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries. European Journal of Molecular & Clinical Medicine, 2022; 9(6): 2535-2546.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 17
  • PDF Download: 29
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus